Dr. Sana Rehman, MD

Dr. Rehman practices at OhioHealth Riverside Methodist Hospital in Columbus, Ohio, part of OhioHealth.

Dr. Rehman's NPI, 1497012256, was assigned on April 18, 2012. Dr. Rehman graduated from Northwestern University Feinberg Medical School in 2012. Dr. Rehman holds Ohio license 35.131611.

Dr. Rehman's primary practice is OhioHealth Riverside Methodist Hospital, at 3535 Olentangy River Rd, Columbus, OH 43214 in Franklin County. The practice phone is (614) 566-5000.

Dr. Rehman's primary practice is OhioHealth Riverside Methodist Hospital in Columbus, Ohio, part of OhioHealth. Dr. Rehman is also affiliated with OhioHealth Grant Medical Center. The medical group on file is Riverside Radiation Oncology. Dmand AI also links Dr. Rehman to 3 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rehman practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Rehman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Rehman is licensed in Ohio.

CMS data shows 1,814 Medicare services from Dr. Rehman across 21 procedure codes in 2024, for 341 Medicare patients. Medicare paid $124,348 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 341 Medicare patients who saw Dr. Rehman in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have cancer, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rehman's median patient age at 72, with 60% women.

In 2024, Dr. Rehman wrote 122 Medicare Part D claims for 65 patients. 87% of them were for generic drugs. CMS names the drug for 41 of them, across 3 drugs with 11 or more claims each, at $893 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Rehman for performance year 2024, reported as part of a group. Dr. Rehman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rehman as offering telehealth.

Dmand AI links 25 papers to Dr. Rehman, published from 2010 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Radiosurgery. Dr. Rehman has published most often in Pract Radiat Oncol. Dr. Rehman's most frequent co-authors are Michael C. Roach, MD, Vivek Srikar Yedavalli, MD and Kavita Gulati, MD.

CMS Open Payments shows 5 general payments to Dr. Rehman from 4 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Incyte Corporation paid the most, $156. It also lists 1 research payment totaling $686 in 2021.

Dr. Rehman graduated from Northwestern University Feinberg Medical School in 2012.